Is Catalyst Pharmaceuticals Still a Bargain After Pipeline Expansion and 8% Weekly Gain? [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (CPRX)
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catalystpharma.com
Company Research
Source: Yahoo! Finance
Catalyst's share price has climbed 8.4% over the last week and is up 12.5% over the past year, hinting at both growing optimism and a shift in the way investors are weighing its potential. Recent news of an expanded product pipeline and positive updates in regulatory proceedings have been fueling investor confidence, making the stock a frequent topic of conversation. These developments put Catalyst in the spotlight and help explain why its price has been trending higher. On our valuation checks, Catalyst Pharmaceuticals earns a 6/6 score . This suggests it may be undervalued across several measures. Let's explore the methods behind that number and consider whether there may be an even smarter way to judge value by the end of this article. Find out why Catalyst Pharmaceuticals's 12.5% return over the last year is lagging behind its peers. Approach 1: Catalyst Pharmaceuticals Discounted Cash Flow (DCF) Analysis A Discounted Cash Flow (DCF) model estimates a company's intrinsi
Show less
Read more
Impact Snapshot
Event Time:
CPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPRX alerts
High impacting Catalyst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CPRX
News
- Is There Still Value in Catalyst Pharmaceuticals After Its 540% Five Year Surge? [Yahoo! Finance]Yahoo! Finance
- Catalyst: Firdapse Cliff Deferred, But Capital Allocation Still An Issue (Upgrade) [Seeking Alpha]Seeking Alpha
- A Fresh Look at Catalyst Pharmaceuticals (CPRX) Valuation Following Recent Share Price Momentum [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual ConferenceGlobeNewswire
- Catalyst Pharmaceuticals Recognized as One of North America’s Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500™GlobeNewswire
CPRX
Earnings
- 11/5/25 - Beat
CPRX
Sec Filings
- 12/3/25 - Form 4
- 11/28/25 - Form 4
- 11/26/25 - Form 144
- CPRX's page on the SEC website